Areva Pharmaceuticals is pleased to announce their continuous certification as a Minority Business Enterprise (MBE) and a Women’s Business Enterprise (WBE). The diversity-based certifications, appointed by the Mid-States Minority Supplier Development Council (MSDC) and the Women’s Business Enterprise National Council (WBENC), have secured Areva’ status as an MBE and WBE diverse supplier through 2021.
“Areva Pharmaceuticals is very proud to be a Woman-owned, Minority-owned enterprise,” says Irene Swaminathan, President and Chair women of Areva Pharmaceuticals. “Moreover, we feel strongly about supporting other diverse enterprises, especially in healthcare.
To become an MSDC Certified Minority Business Enterprise (MBE), a minority business must be at least 51% minority-owned, operated, and controlled. Areva Pharmaceuticals has been a woman-led, minority-owned company since its inception in 2009.
Areva Pharmaceuticals Inc., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Areva ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most.